On the public citation graph
A Biomaterial Screening Approach Reveals Microenvironmental Mechanisms of Drug Resistance
0 signed · 65 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/adma.201103574openalex-snapshot
Maleimide Cross‐Linked Bioactive PEG Hydrogel Exhibits Improved Reaction Kinetics and Cross‐Linking for Cell Encapsulation and In Situ Delivery
inferredcites →https://doi.org/10.1002/bit.25709openalex-snapshot
Three‐dimensional matrix stiffness and adhesive ligands affect cancer cell response to toxins
inferredcites →https://doi.org/10.1016/j.biomaterials.2010.07.064openalex-snapshot
Bioengineered 3D platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells
inferredcites →https://doi.org/10.1016/j.biomaterials.2014.03.058openalex-snapshot
Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening
inferredcites →https://doi.org/10.1016/j.biomaterials.2015.04.058openalex-snapshot
Regulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR
inferredcites →https://doi.org/10.1016/j.ccell.2015.03.008openalex-snapshot
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
inferredcites →https://doi.org/10.1016/j.ccr.2005.08.010openalex-snapshot
Tensional homeostasis and the malignant phenotype
inferredcites →https://doi.org/10.1016/j.ccr.2010.11.023openalex-snapshot
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
inferredcites →https://doi.org/10.1016/j.ccr.2011.11.004openalex-snapshot
Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia
inferredcites →https://doi.org/10.1016/j.ccr.2011.12.024openalex-snapshot
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
inferredcites →https://doi.org/10.1016/j.cell.2009.10.027openalex-snapshot
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
inferredcites →https://doi.org/10.1016/j.cell.2012.02.053openalex-snapshot
Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1016/j.cell.2012.03.031openalex-snapshot
Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
inferredcites →https://doi.org/10.1016/j.celrep.2015.03.037openalex-snapshot
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
inferredcites →https://doi.org/10.1016/j.ctrv.2016.12.001openalex-snapshot
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK
inferredcites →https://doi.org/10.1016/j.jmbbm.2015.06.023openalex-snapshot
Mechanics of intact bone marrow
inferredcites →https://doi.org/10.1016/j.yexcr.2015.10.033openalex-snapshot
Mechanosensing via cell-matrix adhesions in 3D microenvironments
inferredcites →https://doi.org/10.1016/s1040-8428(00)00086-xopenalex-snapshot
Multicellular resistance: a paradigm for clinical resistance?
inferredcites →https://doi.org/10.1016/s1535-6108(03)00058-8openalex-snapshot
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
inferredcites →https://doi.org/10.1021/acsbiomaterials.7b00069openalex-snapshot
Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug Screening
inferredcites →https://doi.org/10.1021/bm400418gopenalex-snapshot
PEG-Phosphorylcholine Hydrogels As Tunable and Versatile Platforms for Mechanobiology
inferredcites →https://doi.org/10.1021/mp500059qopenalex-snapshot
A 3D Biomimetic Model of Tissue Stiffness Interface for Cancer Drug Testing
inferredcites →https://doi.org/10.1038/415530aopenalex-snapshot
Gene expression profiling predicts clinical outcome of breast cancer
inferredcites →https://doi.org/10.1038/ncb2953openalex-snapshot
An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
inferredcites →https://doi.org/10.1038/ncomms12624openalex-snapshot
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
inferredcites →https://doi.org/10.1038/ng1180openalex-snapshot
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
inferredcites →https://doi.org/10.1038/nm.3394openalex-snapshot
Microenvironmental regulation of tumor progression and metastasis
inferredcites →https://doi.org/10.1038/nmeth.3853openalex-snapshot
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
inferredcites →https://doi.org/10.1038/nprot.2012.016openalex-snapshot
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
inferredcites →https://doi.org/10.1039/c6ib00229copenalex-snapshot
PEG–peptide hydrogels reveal differential effects of matrix microenvironmental cues on melanoma drug sensitivity
inferredcites →https://doi.org/10.1056/nejmoa044238openalex-snapshot
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
inferredcites →https://doi.org/10.1073/pnas.0506580102openalex-snapshot
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
inferredcites →https://doi.org/10.1073/pnas.1611338113openalex-snapshot
Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias
inferredcites →https://doi.org/10.1073/pnas.95.26.15665openalex-snapshot
A multidrug resistance transporter from human MCF-7 breast cancer cells
inferredcites →https://doi.org/10.1074/jbc.m112.349365openalex-snapshot
α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
inferredcites →https://doi.org/10.1093/jnci/djm135openalex-snapshot
Drug Resistance and the Solid Tumor Microenvironment
inferredcites →https://doi.org/10.1093/nar/gkw343openalex-snapshot
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update
inferredcites →https://doi.org/10.1126/scisignal.2004155openalex-snapshot
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
inferredcites →https://doi.org/10.1126/scitranslmed.aai8504openalex-snapshot
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
inferredcites →https://doi.org/10.1158/0008-5472.can-08-4490openalex-snapshot
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
inferredcites →https://doi.org/10.1158/0008-5472.can-09-4032openalex-snapshot
Disruption of Laminin-Integrin-CD151-Focal Adhesion Kinase Axis Sensitizes Breast Cancer Cells to ErbB2 Antagonists
inferredcites →https://doi.org/10.1158/0008-5472.can-16-0123openalex-snapshot
JNK Pathway Activation Modulates Acquired Resistance to EGFR/HER2–Targeted Therapies
inferredcites →https://doi.org/10.1158/0008-5472.can-16-2808openalex-snapshot
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-1978openalex-snapshot
A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-3377openalex-snapshot
MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma
inferredcites →https://doi.org/10.1158/2159-8290.cd-15-0933openalex-snapshot
Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance
inferredcites →https://doi.org/10.1186/bcr2936openalex-snapshot
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
inferredcites →https://doi.org/10.1186/bcr3650openalex-snapshot
RETRACTED ARTICLE: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models
inferredcites →https://doi.org/10.1200/jco.2007.14.5375openalex-snapshot
Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
inferredcites →https://doi.org/10.1200/jco.2008.21.4437openalex-snapshot
Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2009.27.9414openalex-snapshot
Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1200/jco.2011.35.7376openalex-snapshot
First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
inferredcites →https://doi.org/10.1242/jcs.144378openalex-snapshot
Metastatic ovarian cancer cell malignancy is increased on soft matrices through a mechanosensitive Rho/ROCK pathway
inferredcites →https://doi.org/10.1242/jcs.188102openalex-snapshot
Comparison of cancer cells cultured in 2D vs 3D reveals differences in AKT/mTOR/S6-kinase signaling and drug response
inferredcites →https://doi.org/10.1371/journal.pone.0019144openalex-snapshot
Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression
inferredcites →https://doi.org/10.1371/journal.pone.0019929openalex-snapshot
A Multiwell Platform for Studying Stiffness-Dependent Cell Biology
inferredcites →https://doi.org/10.1371/journal.pone.0101771openalex-snapshot
Microenvironmental Stiffness Enhances Glioma Cell Proliferation by Stimulating Epidermal Growth Factor Receptor Signaling
inferredcites →https://doi.org/10.1371/journal.pone.0108283openalex-snapshot
3-Dimensional Culture Systems for Anti-Cancer Compound Profiling and High-Throughput Screening Reveal Increases in EGFR Inhibitor-Mediated Cytotoxicity Compared to Monolayer Culture Systems
inferredcites →https://doi.org/10.15252/msb.20145877openalex-snapshot
Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c‐Jun pathway in adaptive resistance to drug‐induced apoptosis
inferredcites →https://doi.org/10.15252/msb.20166796openalex-snapshot
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state
inferredcites →https://doi.org/10.1530/erc-11-0155openalex-snapshot
Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro
inferredcites →https://doi.org/10.1615/critrevoncog.v17.i1.20openalex-snapshot
Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications
inferredcites →https://doi.org/10.4161/cc.9.9.11483openalex-snapshot
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
inferredcites →https://doi.org/10.7554/elife.01308openalex-snapshot
Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1063/1.5019196openalex-snapshot
Anomalously diffusing and persistently migrating cells in 2D and 3D culture environments
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.